RxDoctor Payments Data

Kevin Oksanen

Nurse Practitioner · Saint Louis, MONPI 1316668940

Payments from drug & device makers

$3,903in general payments, 2019–2025

Across 11 payments — averaging $354.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acumed LLC$2K
  • Integra Lifesciences Corporation$1K
  • Elite Orthopedics, LLC$176
  • Kerecis Limited$140
  • Acera Surgical, Inc.$122
  • KCI USA, Inc.$21
  • plus $31 from 2 others

What the payments were for

  • Food & beverage$49013%
  • Education$2,35760%
  • Other$1,05627%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Acumed LLC1$2,357
Integra Lifesciences Corporation3$1,056
Elite Orthopedics, LLC2$176
Kerecis Limited1$140
Acera Surgical, Inc.1$122
KCI USA, Inc.1$21
Hollister Incorporated1$18
Smith+Nephew1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,903 in reported general payments places this provider in the 90th percentile of 1,898 nurse practitioner providers in Missouri.

See all nurse practitioner providers in Missouri

Medicare billing

Part B allowed, 2024
$3,869
Medicare patients
30
Services billed
54

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron31$280
Celecoxib22$191
Cyclobenzaprine Hcl11$45
Meloxicam18$29

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →